Reterro and Munich Re Offer Industry First Substitute Performance Cover for Innovative Soil Remediation

LIVERMORE, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- Reterro, Inc., the only fully vertically integrated Brownfield redevelopment company able to eliminate distressed property liabilities safely and sustainably, and Munich Re (Group), one of the world’s leading reinsurance companies, have partnered to provide the industry’s first process substitute performance cover for … [Read more...]

Five U.S. Cities Named Most Water Wise

IRVINE, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- Residents from more than 4,800 cities across the United States took part in the 2017 Wyland National Mayor’s Challenge for Water Conservation, April 1-30, by pledging to save over 2.2 billion gallons of water over the next year. The annual month-long campaign to promote drought resiliency and water quality ended on April … [Read more...]

American Health Council Names Jeffrey Scifert, PhD to Industry Board

NEW YORK, May 18, 2017 (GLOBE NEWSWIRE) -- Dr. Jeffrey Scifert, Senior Engineering Program Manager at Medtronic, has been selected to join the Industry Board at the American Health Council. He will be sharing his knowledge and expertise in Healthcare Education, Workforce Development, Business, and Biologics R&D. With over sixteen years of experience in the healthcare … [Read more...]

CytoDyn Treats First Patient with PRO 140 in Phase 2 Trial for Graft versus Host Disease

VANCOUVER, Washington, May 17, 2017 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating human immunodeficiency virus (HIV) infection, announces the treatment of the first patient in its Phase 2 clinical trial for Graft versus Host Disease (GvHD), its leading immunologic indication for PRO 140. GvHD … [Read more...]

Ascendant Solutions, Inc. Reports First Quarter 2017 Earnings; Shareholders Approve Name Change to Dougherty’s Pharmacy

DALLAS, May 11, 2017 (GLOBE NEWSWIRE) -- Ascendant Solutions, Inc. (Pink Sheets:ASDS) (“Ascendant” or the “Company”) today announced its results for the first quarter of fiscal 2017.  Highlights First quarter 2017 EBITDA improved $49,000 or 30.2%Gross profit margin increased from 27.0% to 27.7% compared to 2016 first quarterThe generic dispensing rate increased from … [Read more...]